September 8, 2017 — Endovascular simulation solution provider Mentice announced the release of a new simulation training software for transarterial chemoembolization (TACE). The new software will be showcased at the 2017 Cardiovascular and Interventional Radiological Society of Europe (CIRSE) Congress, to be held Sept. 16-20 in Copenhagen, Denmark.
TACE is an effective, widely performed therapy performed by interventional radiologists (IRs). It is a minimally invasive procedure for liver cancer that delivers chemotherapy drugs and embolization agents with great accuracy, minimizing side effects for patients. It is, however, a challenging procedure that involves various sub-techniques, complex anatomies and variant vasculatures requiring the extensive use of radiation. Success of the procedure and impact on cost is tied to the ability to complete it safely and accurately within the permitted radiation doses.
The Mentice TACE training solution is based on real-life cases, providing the realism essential for successful training and features an integrated radiation safety module, that provides dose monitoring for patient and staff at all times. The software also features output of metrics, enabling objective assessment of trainees’ progress.
Attendees at CIRSE can test the new Mentice TACE training software at the company’s booth. The software will also be available for testing and demonstrations at ‘The Basics of Chemoembolization for the Liver’ session being held as part of the ‘Principles to Practice: Education and Simulation Skills Training’ program.
For more information: www.mentice.com